"Board certified Medical Oncology/Hematology office"

During the past decade, South Carolina Cancer Specialists PC conducted 41 clinical trials. In the 10-year time frame, 41 clinical trials started and 8 clinical trials were completed, i.e. on average, 19.5% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 4 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "South Carolina Cancer Specialists PC" #1 sponsor was "National Cancer Institute (NCI)" with 17 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NRG Oncology" with 5 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 4 trials sponsored and "SWOG Cancer Research Network" with 4 trials sponsored. Other sponsors include 10 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "South Carolina Cancer Specialists PC" #1 collaborator was "National Cancer Institute (NCI)" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 4 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Bayer" with 2 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "South Carolina Cancer Specialists PC" are "Invasive Breast Carcinoma" (5 trials), "Anatomic Stage II Breast Cancer AJCC v8" (4 trials), "Anatomic Stage IIA Breast Cancer AJCC v8" (4 trials), "Anatomic Stage IIB Breast Cancer AJCC v8" (4 trials) and "Anatomic Stage IIIA Breast Cancer AJCC v8" (4 trials). Many other conditions were trialed in "South Carolina Cancer Specialists PC" in a lesser frequency.

Most popular intervention types in "South Carolina Cancer Specialists PC" are "Drug" (41 trials), "Other" (32 trials), "Biological" (15 trials), "Procedure" (15 trials) and "Radiation" (5 trials). Other intervention types were less common.

The name of intervention was led by "Quality-of-Life Assessment" (15 trials), "Questionnaire Administration" (13 trials), "Paclitaxel" (11 trials), "Biospecimen Collection" (10 trials) and "Carboplatin" (10 trials). Other intervention names were less common.

The vast majority of trials in "South Carolina Cancer Specialists PC" are 41 trials for "All" genders, 9 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "South Carolina Cancer Specialists PC". undefined are not yet recruiting, 22 are recruiting, 17 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in South Carolina Cancer Specialists PC, 1 suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in South Carolina Cancer Specialists PC, 2 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 30 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".